Eubel Brady & Suttman Asset Management Inc. Buys 389,704 Shares of Kenvue Inc. $KVUE

Eubel Brady & Suttman Asset Management Inc. boosted its stake in Kenvue Inc. (NYSE:KVUE) by 39.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,371,886 shares of the company’s stock after purchasing an additional 389,704 shares during the period. Kenvue comprises 2.6% of Eubel Brady & Suttman Asset Management Inc.’s investment portfolio, making the stock its 17th largest position. Eubel Brady & Suttman Asset Management Inc. owned 0.07% of Kenvue worth $22,266,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in KVUE. TrueMark Investments LLC grew its stake in shares of Kenvue by 8.8% in the second quarter. TrueMark Investments LLC now owns 229,648 shares of the company’s stock worth $4,807,000 after acquiring an additional 18,623 shares during the last quarter. Vanguard Group Inc. boosted its stake in Kenvue by 1.8% in the 2nd quarter. Vanguard Group Inc. now owns 233,246,267 shares of the company’s stock worth $4,881,844,000 after purchasing an additional 4,101,880 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in shares of Kenvue by 27.1% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 310,686 shares of the company’s stock worth $5,042,000 after buying an additional 66,192 shares in the last quarter. Aberdeen Group plc grew its holdings in shares of Kenvue by 15.1% during the second quarter. Aberdeen Group plc now owns 766,450 shares of the company’s stock valued at $16,015,000 after buying an additional 100,403 shares during the last quarter. Finally, Bessemer Group Inc. increased its holdings in shares of Kenvue by 40.6% in the 2nd quarter. Bessemer Group Inc. now owns 3,319,933 shares of the company’s stock worth $69,487,000 after purchasing an additional 958,757 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft set a $18.00 target price on shares of Kenvue in a research note on Friday, October 24th. Barclays raised their target price on Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Monday, November 10th. Johnson Rice reaffirmed a “neutral” rating on shares of Kenvue in a research report on Tuesday, October 28th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Kenvue in a report on Friday, January 9th. Finally, Canaccord Genuity Group reiterated a “hold” rating and set a $15.00 price target (down previously from $26.00) on shares of Kenvue in a research note on Wednesday, October 29th. Four equities research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $19.46.

Insider Transactions at Kenvue

In related news, Director Jeffrey C. Smith acquired 3,200,000 shares of Kenvue stock in a transaction dated Friday, December 12th. The shares were purchased at an average price of $17.37 per share, for a total transaction of $55,584,000.00. Following the completion of the transaction, the director directly owned 27,307,632 shares in the company, valued at approximately $474,333,567.84. This represents a 13.27% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.68% of the stock is currently owned by company insiders.

Kenvue Price Performance

Shares of Kenvue stock opened at $18.50 on Thursday. The company has a market capitalization of $35.44 billion, a price-to-earnings ratio of 24.67 and a beta of 0.59. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. The stock’s 50-day simple moving average is $17.32 and its 200-day simple moving average is $17.78. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $25.17.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th will be paid a $0.2075 dividend. This represents a $0.83 annualized dividend and a yield of 4.5%. The ex-dividend date is Wednesday, February 11th. Kenvue’s dividend payout ratio is presently 110.67%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.